Titre : Tabac pour pipe à eau

Tabac pour pipe à eau : Questions médicales fréquentes

Termes MeSH sélectionnés :

Antisocial Personality Disorder

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment diagnostiquer une dépendance au tabac à pipe à eau ?

Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage.
Dépendance au tabac Diagnostic médical
#2

Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?

Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé.
Fonction pulmonaire Tests diagnostiques

Symptômes 2

#1

Quels sont les symptômes d'une consommation excessive ?

Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires.
Toux Essoufflement
#2

Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?

Il peut causer des maladies des gencives, des caries et des taches sur les dents.
Santé bucco-dentaire Maladies des gencives

Prévention 2

#1

Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?

L'éducation sur les risques et la promotion d'activités alternatives sont essentielles.
Prévention du tabagisme Éducation à la santé
#2

Quelles campagnes sont efficaces contre le tabac à pipe à eau ?

Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs.
Campagnes de santé publique Tabagisme

Traitements 2

#1

Quels traitements existent pour arrêter le tabac à pipe à eau ?

Les traitements incluent les thérapies comportementales et les substituts nicotiniques.
Thérapie comportementale Substituts nicotiniques
#2

Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?

Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer.
Varénicline Médicaments anti-tabac

Complications 2

#1

Quelles sont les complications respiratoires liées au tabac à pipe à eau ?

Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon.
Bronchite chronique Cancer du poumon
#2

Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?

Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine.
Maladies cardiovasculaires Circulation sanguine

Facteurs de risque 2

#1

Quels sont les principaux facteurs de risque du tabac à pipe à eau ?

Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs.
Facteurs de risque Tabagisme
#2

Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?

Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse.
Grossesse Tabagisme
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tabac pour pipe à eau : Questions médicales les plus fréquentes", "headline": "Tabac pour pipe à eau : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tabac pour pipe à eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-20", "dateModified": "2025-02-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Produits du tabac", "url": "https://questionsmedicales.fr/mesh/D062789", "about": { "@type": "MedicalCondition", "name": "Produits du tabac", "code": { "@type": "MedicalCode", "code": "D062789", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844" } } }, "about": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau", "alternateName": "Tobacco, Waterpipe", "code": { "@type": "MedicalCode", "code": "D000073846", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Omar F Khabour", "url": "https://questionsmedicales.fr/author/Omar%20F%20Khabour", "affiliation": { "@type": "Organization", "name": "Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan." } }, { "@type": "Person", "name": "Karem H Alzoubi", "url": "https://questionsmedicales.fr/author/Karem%20H%20Alzoubi", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan." } }, { "@type": "Person", "name": "Erin L Sutfin", "url": "https://questionsmedicales.fr/author/Erin%20L%20Sutfin", "affiliation": { "@type": "Organization", "name": "Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu." } }, { "@type": "Person", "name": "Jennifer Cornacchione Ross", "url": "https://questionsmedicales.fr/author/Jennifer%20Cornacchione%20Ross", "affiliation": { "@type": "Organization", "name": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA." } }, { "@type": "Person", "name": "Thomas Eissenberg", "url": "https://questionsmedicales.fr/author/Thomas%20Eissenberg", "affiliation": { "@type": "Organization", "name": "Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review.", "datePublished": "2022-05-16", "url": "https://questionsmedicales.fr/article/35575169", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/bsl.2576" } }, { "@type": "ScholarlyArticle", "name": "Pharmacological strategies for the management of the antisocial personality disorder.", "datePublished": "2023-02-22", "url": "https://questionsmedicales.fr/article/36787887", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/17512433.2023.2181159" } }, { "@type": "ScholarlyArticle", "name": "Association patterns of antisocial personality disorder across substance use disorders.", "datePublished": "2024-08-28", "url": "https://questionsmedicales.fr/article/39198385", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41398-024-03054-z" } }, { "@type": "ScholarlyArticle", "name": "Increased ghrelin and decreased leptin levels in patients with antisocial personality disorder.", "datePublished": "2022-08-24", "url": "https://questionsmedicales.fr/article/36028010", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jad.2022.08.048" } }, { "@type": "ScholarlyArticle", "name": "Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients.", "datePublished": "2022-11-20", "url": "https://questionsmedicales.fr/article/36403120", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ajad.13361" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Dispositifs pour fumer", "item": "https://questionsmedicales.fr/mesh/D000074602" }, { "@type": "ListItem", "position": 5, "name": "Produits du tabac", "item": "https://questionsmedicales.fr/mesh/D062789" }, { "@type": "ListItem", "position": 6, "name": "Tabac pour pipe à eau", "item": "https://questionsmedicales.fr/mesh/D000073846" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tabac pour pipe à eau - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tabac pour pipe à eau", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tabac pour pipe à eau", "description": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?\nQuels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Antisocial+Personality+Disorder#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tabac pour pipe à eau", "description": "Quels sont les symptômes d'une consommation excessive ?\nComment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Antisocial+Personality+Disorder#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tabac pour pipe à eau", "description": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?\nQuelles campagnes sont efficaces contre le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Antisocial+Personality+Disorder#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tabac pour pipe à eau", "description": "Quels traitements existent pour arrêter le tabac à pipe à eau ?\nLes médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Antisocial+Personality+Disorder#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tabac pour pipe à eau", "description": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?\nLe tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Antisocial+Personality+Disorder#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tabac pour pipe à eau", "description": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?\nLes femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Antisocial+Personality+Disorder#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une consommation excessive ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires." } }, { "@type": "Question", "name": "Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il peut causer des maladies des gencives, des caries et des taches sur les dents." } }, { "@type": "Question", "name": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sur les risques et la promotion d'activités alternatives sont essentielles." } }, { "@type": "Question", "name": "Quelles campagnes sont efficaces contre le tabac à pipe à eau ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs." } }, { "@type": "Question", "name": "Quels traitements existent pour arrêter le tabac à pipe à eau ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les thérapies comportementales et les substituts nicotiniques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer." } }, { "@type": "Question", "name": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon." } }, { "@type": "Question", "name": "Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 14/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Omar F Khabour

8 publications dans cette catégorie

Affiliations :
  • Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.

Karem H Alzoubi

8 publications dans cette catégorie

Affiliations :
  • Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Erin L Sutfin

7 publications dans cette catégorie

Affiliations :
  • Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu.

Jennifer Cornacchione Ross

7 publications dans cette catégorie

Affiliations :
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Boston University School of Public Health, Boston, Massachusetts, USA.

Thomas Eissenberg

7 publications dans cette catégorie

Affiliations :
  • Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America.
Publications dans "Tabac pour pipe à eau" : Voir toutes les publications (7)

Rima Nakkash

6 publications dans cette catégorie

Affiliations :
  • Department of Health Promotion and Community Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
  • Department of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, VA, United States.

Ramzi G Salloum

5 publications dans cette catégorie

Affiliations :
  • Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Florida, FL, United States.

Mohammed Jawad

5 publications dans cette catégorie

Affiliations :
  • Public Health Policy Evaluation Unit, Imperial College London, Hammersmith, UK.

Ngoan Tran Le

4 publications dans cette catégorie

Affiliations :
  • Institute of Research and Development, Duy Tan University, Da Nang City, Vietnam.
  • Department of Occupational Health, Institute for Preventive Medicine and Public Health, Hanoi Medical University, Ha Noi City, Vietnam.
  • Center for Health Promotion and Research, Hanoi Prospective Cohort Study, Hanoi City, Vietnam.

Can Van Phan

4 publications dans cette catégorie

Affiliations :
  • Center for Health Promotion and Research, Hanoi Prospective Cohort Study, Hanoi City, Vietnam.
  • Center for Population Health Sciences, Hanoi University of Public Health, Ha Noi City, Vietnam.

Phuoc Hong Le

4 publications dans cette catégorie

Affiliations :
  • Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Noura O Kassem

4 publications dans cette catégorie

Affiliations :
  • San Diego State University Research Foundation, San Diego, California, USA.

Allison J Lazard

4 publications dans cette catégorie

Affiliations :
  • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Hussman School of Media and Journalism, University of North Carolina, Chapel Hill, North Carolina, USA.
Publications dans "Tabac pour pipe à eau" :

Brittney Keller-Hamilton

4 publications dans cette catégorie

Affiliations :
  • Mohammed Moumen, Medical Student, Wake Forrest School of Medicine, Winston-Salem, NC. Marielle Brinkman, Senior Research Scientist, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Brittney Keller-Hamilton, Research Scientist, Comprehensive Cancer Center, The Ohio State University, Columbus, OH. Andreas A. Teferra, Doctoral Student, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Megan E. Roberts, Assistant Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Elizabeth G. Klein, Interim Chair and Associate Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Paul Nini, Professor, Department of Design, College of Arts and Sciences, The Ohio State University, Columbus, OH. Michael Pennell, Associate Professor, Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH. Amy K. Ferketich, Professor Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH.

Theodore L Wagener

4 publications dans cette catégorie

Affiliations :
  • Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.

Darren Mays

4 publications dans cette catégorie

Affiliations :
  • Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.

Kenneth D Ward

4 publications dans cette catégorie

Affiliations :
  • Division of Social and Behavioral Science, School of Public Health, University of Memphis, Memphis, TN.

Mohammad Ebrahimi Kalan

4 publications dans cette catégorie

Affiliations :
  • Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, FL, USA.

Sources (10000 au total)

Pharmacological strategies for the management of the antisocial personality disorder.

Antisocial personality disorder (AsPD) is a pervasive pattern of violation of others' rights, related to the concept of psychopathy. AsPD is stable over time from adolescence, with evidence of conduct... We conducted a narrative review and searched PubMed up to September 2022. We included RCTs and naturalistic studies evaluating pharmacological interventions on AsPD in adults, including those with com... Psychosocial interventions are the first option, with possible improvement of CU traits, beyond behavioral and affective symptoms, particularly if implemented early during development. Limited informa...

Increased ghrelin and decreased leptin levels in patients with antisocial personality disorder.

The study aimed to compare acyl ghrelin (AG), des-acyl ghrelin (DAG), and leptin levels considered to be used as biological markers in the etiopathogenesis of antisocial personality disorder (ASPD) wi... The study included 45 patients with ASPD and 61 healthy people in the control group. Sociodemographic data form, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Barratt Impulsiveness Sc... It was found that the mean serum AG and DAG levels were significantly higher than that of healthy controls whereas leptin hormone levels were significantly lower in patients compared to healthy contro... The present study is the first in the literature to examine AG, DAG, and leptin hormone levels of patients diagnosed with ASPD. According to the results of the study, it is believed that changes in se...

Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients.

Antisocial personality disorder (ASPD) is very common among methamphetamine (MA) patients, but very few studies have been conducted in China. This study aimed to investigate the prevalence and clinica... We recruited 627 MA patients and collected demographic and MA use data through one-on-one semi-structured interviews. ASPD was measured by the Mini International Neuropsychiatric Interview (M.I.N.I.).... The prevalence rate of ASPD among MA patients was 27.59% (173/627). Patients with ASPD had greater age at the first onset, duration of MA use, length of abstinence, VAS, DDQ desire and intention, nega... Our findings suggest that the prevalence of ASPD is high among Chinese MA patients. Furthermore, some demographic and clinical variables are associated with ASPD in MA patients.... We focused our study on the clinical profile of ASPD and the reasons for its high prevalence in Chinese methamphetamine patients. We identified several demographic and clinical variables as correlates...

Cascades From Early Adolescent Impulsivity to Late Adolescent Antisocial Personality Disorder and Alcohol Use Disorder.

The behavioral disinhibition model (BDM) posits that a liability toward impulsivity evident by early adolescence underlies the coemergence of antisocial behavior and alcohol use (i.e., problem behavio... We used five-year longitudinal self-report data from the Philadelphia Trajectory Study that was collected from 2006-2012. Mediational analyses were performed using the Random Intercept Cross-lagged Pa... Consistent with the BDM, mediational analyses revealed that changes in early adolescent impulsivity predicted late adolescent APD and AUD criteria, mediated by changes in mid-adolescent alcohol use an... Interventions targeting impulsivity in early adolescence could potentially halt the cascading chain of events leading to both late adolescent APD and AUD by decelerating growth in antisocial behavior ...

Establishing an optimal working relationship with patients with an antisocial personality disorder. Aspects and processes in the therapeutic alliance.

Developing good interpersonal relationships is one of the main impediments for people with an antisocial personality disorder (ASPD). However, in treatment of psychiatric disorders, establishing a str... For this study, a qualitative research methodology is applied. In-depth interviews with therapists experienced in treating ASPD were conducted and analysed through thematic analysis.... The analysis revealed six themes important in alliance formation: the patient's needs, regulating interpersonal dynamics, connective attitude, connective skills, treatment process and treatment goals.... This study determined that, for therapists working with patients with ASPD, several key factors are essential in establishing a strong TA. These factors include the ability to be firm, authentic, non-...